Rapid quantification of myocardial lipid content in humans using single breath-hold 1H MRS at 3 Tesla

Magnetic Resonance in Medicine

Volumn 66, Issue 3, 2011, Pages 619-624

  Rial, Belen ^a   Robson, Matthew D ^a   Neubauer, Stefan ^a   Schneider, Jürgen E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

3 T; breath holding; cardiac magnetic resonance spectroscopy; lipid; quantification

Indexed keywords

LIPIDS; MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SPECTROSCOPIC ANALYSIS;

BREATH-HOLDING; COEFFICIENT OF VARIATION; HEALTHY VOLUNTEERS; PHASED ARRAY COILS; QUANTIFICATION; REPEATED MEASUREMENTS; REPRODUCIBILITIES; STIMULATED ECHOS;

SIGNAL TO NOISE RATIO;

CREATINE; LIPID; MYOCARDIAL LIPID; TRIMETHYLAMMONIUM SALT DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; BREATH HOLDING; CALIBRATION; ELECTROCARDIOGRAM; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOFREQUENCY; SHORT ECHO TIME SPECTROSCOPIC STIMULATED ECHO SEQUENCE; SPECTROSCOPY; WHOLE BODY MRI;

EID: 80051676691     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.23011     Document Type: Article

References (29)

1. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W, Unger R, Victor RG,. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003; 49: 417-423. (Pubitemid 36262808)
2. Reingold JS, McGavock JM, Kaka S, Tillery T, Victor RG, Szczepaniak LS,. Determination of triglyceride in the human myocardium by magnetic resonance spectroscopy: reproducibility and sensitivity of the method. Am J Physiol Endocrinol Metab 2005; 289: E935-939. (Pubitemid 41504396)
3. van der Meer RW, Doornbos J, Kozerke S, Schar M, Bax JJ, Hammer S, Smit JW, Romijn JA, Diamant M, Rijzewijk LJ, de Roos A, Lamb HJ,. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 2007; 245: 251-257. (Pubitemid 47417809)
4. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K, Noon GP, Frazier OH, Taegtmeyer H,. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J 2004; 18: 1692-1700. (Pubitemid 39463708)
5. Rijzewijk LJ, van der Meer RW, Smit JW, Diamant M, Bax JJ, Hammer S, Romijn JA, de Roos A, Lamb HJ,. Myocardial steatosis is an independent predictor of diastolic dysfunction in type 2 diabetes mellitus. J Am Coll Cardiol 2008; 52: 1793-1799.
6. Szczepaniak LS, Victor RG, Orci L, Unger RH,. Forgotten but not gone: the rediscovery of fatty heart, the most common unrecognized disease in America. Circ Res 2007; 101: 759-767. (Pubitemid 350287190)
7. Hammer S, van der Meer RW, Lamb HJ, de Boer HH, Bax JJ, de Roos A, Romijn JA, Smit JW,. Short-term flexibility of myocardial triglycerides and diastolic function in patients with type 2 diabetes mellitus. Am J Physiol 2008; 295: E714-E718.
8. Tyler DJ, Hudsmith LE, Clarke K, Neubauer S, Robson MD,. A comparison of cardiac (31)P MRS at 1.5 and 3 T. NMR Biomed 2008; 21: 793-798.
9. Noeske R, Seifert F, Rhein KH, Rinneberg H,. Human cardiac imaging at 3 T using phased array coils. Magn Reson Med 2000; 44: 978-982.
10. Felblinger J, Jung B, Slotboom J, Boesch C, Kreis R,. Methods and reproducibility of cardiac/respiratory double-triggered (1)H-MR spectroscopy of the human heart. Magn Reson Med 1999; 42: 903-910. (Pubitemid 29521480)
11. Schar M, Kozerke S, Boesiger P,. Navigator gating and volume tracking for double-triggered cardiac proton spectroscopy at 3 Tesla. Magn Reson Med 2004; 51: 1091-1095. (Pubitemid 38796991)
12. Gabr RE, Sathyanarayana S, Schar M, Weiss RG, Bottomley PA,. On restoring motion-induced signal loss in single-voxel magnetic resonance spectra. Magn Reson Med 2006; 56: 754-760. (Pubitemid 44477658)
13. Liu CY, Redheuil A, Ouwerkerk R, Lima JA, Bluemke DA,. Myocardial fat quantification in humans: Evaluation by two-point water-fat imaging and localized proton spectroscopy. Magn Reson Med 2010; 63: 892-901.
14. Jahnke C, Paetsch I, Achenbach S, Schnackenburg B, Gebker R, Fleck E, Nagel E,. Coronary MR imaging: breath-hold capability and patterns, coronary artery rest periods, and beta-blocker use. Radiology 2006; 239: 71-78.
15. Marks B, Mitchell DG, Simelaro JP,. Breath-holding in healthy and pulmonary-compromised populations: effects of hyperventilation and oxygen inspiration. J Magn Reson Imaging 1997; 7: 595-597. (Pubitemid 28360881)
16. Ogg RJ, Kingsley PB, Taylor JS,. WET, a T1- and B1-insensitive water-suppression method for in vivo localized 1H NMR spectroscopy. J Magn Reson B 1994; 104: 1-10.
17. Roemer PB, Edelstein WA, Hayes CE, Souza SP, Mueller OM,. The NMR phased array. Magn Reson Med 1990; 16: 192-225.
18. Vanhamme L, van den Boogaart A, Van Huffel S,. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997; 129: 35-43. (Pubitemid 127454051)
19. Lamb HJ, Doornbos J, den Hollander JA, Luyten PR, Beyerbacht HP, van der Wall EE, de Roos A,. Reproducibility of human cardiac 31P-NMR spectroscopy. NMR Biomed 1996; 9: 217-227.
20. Bottomley PA, Weiss RG,. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998; 351: 714-718. (Pubitemid 28105341)
21. den Hollander JA, Evanochko WT, Pohost GM,. Observation of cardiac lipids in humans by localized 1H magnetic resonance spectroscopic imaging. Magn Reson Med 1994; 32: 175-180. (Pubitemid 24243297)
22. Kreis R,. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004; 17: 361-381. (Pubitemid 39335175)
23. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obesity Res 1998; 6 (Suppl 2): 1-230.
24. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E, Knuuti J, Nuutila P, Parkkola R, Iozzo P,. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006; 91: 4689-4695. (Pubitemid 44833458)
25. Nakae I, Mitsunami K, Yoshino T, Omura T, Tsutamoto T, Matsumoto T, Morikawa S, Inubushi T, Horie M,. Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine. J Card Fail 2010; 16: 812-822.
26. Piechnik S, Ferreira V, Dall'Armellina E, Cochlin L, Greiser A, Neubauer S, Robson M,. Shortened modified look-locker inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010; 12: 69.
27. Hammer S, van der Meer RW, Lamb HJ, Schar M, de Roos A, Smit JW, Romijn JA,. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 2008; 93: 497-503. (Pubitemid 351240822)
28. Nakae I, Mitsunami K, Omura T, Yabe T, Tsutamoto T, Matsuo S, Takahashi M, Morikawa S, Inubushi T, Nakamura Y, Kinoshita M, Horie M,. Proton magnetic resonance spectroscopy can detect creatine depletion associated with the progression of heart failure in cardiomyopathy. J Am Coll Cardiol 2003; 42: 1587-1593. (Pubitemid 37378437)
29. Bottomley PA, Weiss RG,. Noninvasive localized MR quantification of creatine kinase metabolites in normal and infarcted canine myocardium. Radiology 2001; 219: 411-418. (Pubitemid 32336354)